[Partial myeloblastoses].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000367:Age Factors; D000728:Androgens / Q000627:therapeutic use; D000740:Anemia / Q000209:etiology; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001772:Blood Cell Count; D001792:Blood Platelets / Q000473:pathology; D001799:Blood Sedimentation; D001853:Bone Marrow / Q000473:pathology*; D001854:Bone Marrow Cells; D003201:Computers; D004912:Erythrocytes / Q000473:pathology; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000145:classification* / Q000175:diagnosis / Q000188:drug therapy; D007962:Leukocytes / Q000473:pathology; D011379:Prognosis; D013223:Statistics as Topic; D014815:Vitamins / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000728:Androgens; D000970:Antineoplastic Agents; D006454:Hemoglobins; D014815:Vitamins
Les myéloblastoses partielles